SCHEMBL10598481

SCHEMBL10598481

C[C@]12CCC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.83
▸ HIF1A Q16665 13/20 0.70
▸ HSD17B10 Q99714 8/20 0.70
▸ CYP3A4 P08684 8/20 0.70
▸ NR3C1 P04150 5/20 0.70
▸ PGR P06401 5/20 0.70
▸ CYP2C19 P33261 4/20 0.70
▸ SERPINA6 P08185 4/20 0.70
▸ SMN1; SMN2 Q16637 3/20 0.70
▸ SHBG P04278 2/20 0.70
▸ NR3C2 P08235 2/20 0.70
▸ MAPT P10636 1/20 0.70
▸ NFKB1 P19838 1/20 0.70
▸ ABCB11 O95342 3/20 0.65
▸ AR P10275 3/20 0.65
▸ NPSR1 Q6W5P4 1/20 0.65
▸ ALDH1A1 P00352 2/20 0.65
▸ TSHR P16473 2/20 0.65
▸ CYP2C9 P11712 1/20 0.65
▸ ABCC4 O15439 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10598493 1.00 KMT2A (0.83) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL142384 0.91 KMT2A (1.00) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL142385 0.91 KMT2A (1.00) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL142686 0.91 KMT2A (1.00) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL137530 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL17714999 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL17726095 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL137529 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL10393880 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1
SCHEMBL13150977 0.90 KMT2A (0.84) KMT2AHIF1AHSD17B10CYP3A4NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119278054-A Glycosylated prodrugs 莱顿大学 2025-01-07 — — CN claimed
US-20230332237-A1 Molecular Biomarkers for Predicting Patient Response to Steroid Therapy NATIONAL INSTITUTES OF HEALTH 2023-10-19 — — US claimed
EP-0186948-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 17ALPHA-HYDROXYPROGESTERONES AND CORTICOIDS FROM AN ENOL STEROID THE UPJOHN COMPANY (US) 1989-01-25 — — EP claimed
EP-0186948-A1 Process and intermediates for the preparation of 17alpha-hydroxyprogesterones and corticoids from an enol steroid THE UPJOHN COMPANY (US) 1986-07-09 — — EP claimed
US-20230332237-A1 Molecular Biomarkers for Predicting Patient Response to Steroid Therapy NATIONAL INSTITUTES OF HEALTH 2023-10-19 — — US disclosed
WO-2010121814-A1 PHARMACEUTICAL COMPOSITION, COMPRISING A STEROID-DEHYDROGENASE-REDUCTASE INHIBITOR, AND A MINERALOCORTICOID RECEPTOR ANTAGONIST ONTOCHEM GMBH (DE) 2010-10-28 — — WO disclosed
EP-0186948-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF 17ALPHA-HYDROXYPROGESTERONES AND CORTICOIDS FROM AN ENOL STEROID THE UPJOHN COMPANY (US) 1989-01-25 — — EP disclosed
US-4613463-A Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid THE UPJOHN COMPANY (US) 1986-09-23 — — US disclosed
EP-0042451-B1 PROCESS FOR THE PREPARATION OF 11-BETA-HYDROXY STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1983-06-22 — — EP disclosed
US-4353985-A FERMENTATION WITH CURVULARIA SCHERING AKTIENGESELLSCHAFT (DE) 1982-10-12 — — US disclosed
Send feedback